Drug Use and Addiction Research Programs federal funding in FY2025

How CFDA 93.279 meets FY2025 in the award file

This page is a join: Drug Use And Addiction Research Programs and fiscal year 2025. $1,661,637,959.86 is the USAspending.gov obligation sum on the yearlyTrend row that carries both tags. It is not every federal dollar in FY2025, not an outlay register, and not a treatment-admission census, an overdose map, or a neurosciences-research twin. The FY cell is 13.9% of the program-wide $11,966,347,937.16 book in this extract. A different fiscal year for CFDA 93.279 is a separate overlay. Campaign-finance tables are a different dataset; FEC donations do not fund these USAspending obligations.

CFDA 93.279 is the listing without the year filter. FY2025 federal spending is the year without this CFDA filter. All programs lists other catalog hubs. All spending ties indexes other pairs. Only this tie applies both filters. 1,130 is the year-cell award-record count; the program parent lists 5,019 awards across the extract. Those counts are different tables.

Drug Use and Addiction Research as the program side of the FY2025 join

The official title is DRUG USE AND ADDICTION RESEARCH PROGRAMS. SpendingVault does not grade Drug Use and Addiction Research. $1,661,637,959.86 is an obligation sum, not a verdict. Confusing this join with neurosciences extramural research or other NIH catalog lines that are not CFDA 93.279 would be a different table. Packet facts on the program side are the name Drug Use And Addiction Research Programs, number 93.279, program-wide obligations $11,966,347,937.16, and 5,019 awards on the parent. This packet lists no award recipients and no contractor names.

Drug Use And Addiction Research Programs is CFDA 93.279. FY2025 obligations on that listing are a yearlyTrend sum, not a count of papers or patients. Neurosciences extramural research in this harvest uses CFDA 93.853. Mixing those listings would invent a combined NIH research total the packet never computed. Investigator names are unpublished.

What fiscal year 2025 contributes on CFDA 93.279

FY2025 is a USAspending yearlyTrend bucket, not a calendar-year close and not a claim that every obligated dollar was delivered inside calendar 2025. Awards can list FY2025 while performance stretches across adjacent years. FY figures can be incomplete for a current year; this snapshot reports $1,661,637,959.86 as given. Other fiscal years for CFDA 93.279 belong on those ties. Do not treat $11,966,347,937.16 as if it were the FY2025 headline.

1,130 awards on the FY2025 cell, not a unit census

The extract lists 1,130 awards on Drug Use and Addiction Research in FY2025. That is an award-record count, not 1,130 finished studies or 1,130 unique laboratories. Dividing $1,661,637,959.86 by 1,130 yields about $1,470,476.07 as a quotient of two packet facts, not a typical invoice and not a median. Unique recipients are unpublished. Modifications can add rows without naming a new organization. Do not mix $1,661,637,959.86 with the parent’s 5,019 awards.

Obligations on Drug Use and Addiction Research are not cash already cleared in FY2025

An obligation is a legal commitment. An outlay is a payment. $1,661,637,959.86 is the former. Citing it as cash already cleared in FY2025 over-reads the field. The join cannot say that fiscal year 2025 specialized in Drug Use and Addiction Research because of federal demand. Keep $1,661,637,959.86 labeled as Drug Use And Addiction Research Programs obligations in FY2025. It is not a named-lab roster, a clinical-trial registry, or a block-grant overlay.

Open /programs/93.279/ for the program rollup, /fiscal-years/2025/ for the fiscal-year rollup, /programs/ for other CFDA hubs, and /ties/ for other pairs. None of those links convert this cell into a treatment-admission census, an overdose map, or a neurosciences-research twin, into outlays this packet omits, or into a contractor list. Cite both sides: Drug Use And Addiction Research Programs and FY2025, CFDA 93.279, $1,661,637,959.86, 1,130 awards, USAspending.gov, obligations only. Keep Drug Use And Addiction Research Programs and FY2025 on the same line as $1,661,637,959.86.

Questions

How much drug use and addiction research spending is in FY2025?

USAspending.gov records $1,661,637,959.86 in Drug Use And Addiction Research Programs obligations for FY2025 (CFDA 93.279). That is a program × year join, not an outlay and not the government-wide FY2025 total. Original filings remain on USAspending.gov.

Do 1,130 awards mean 1,130 addiction studies finished in FY2025?

No. 1,130 is the year-cell award-record count, not 1,130 finished studies or 1,130 unique laboratories. A mean of about $1,470,476.07 is arithmetic on packet facts, not a typical payment. Unique recipients are unpublished. Original filings remain on USAspending.gov.

Is $1,661,637,959.86 cash already paid for Drug Use and Addiction Research in FY2025?

No. $1,661,637,959.86 is an obligation aggregate for Drug Use And Addiction Research Programs in FY2025. Outlays, remaining balances, and cash already paid are unpublished on this packet. Keep the obligation label. USAspending.gov remains the source.

Which pages parent Drug Use and Addiction Research FY2025?

CFDA 93.279 is the program parent. FY2025 federal spending is the year parent. All programs lists other CFDA hubs. All spending ties lists other pairs. Prefer those tables after later ingests; this page quotes Drug Use And Addiction Research Programs × FY2025 at $1,661,637,959.86.